3. Setting up specifications

3.1 ICH objectives

In the paragraph 1 , it was pointed out why residual solvents should be identified and dosed in pharmaceutical products:

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed? Log in!

Ongoing reading
Setting up specifications

Article included in this offer

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

(1) - The United States Pharmacopoeia, USP-NF43 - Organic volatile impurities, identification, control and quantification of residual solvents <467>. - Éd. : The United States Pharmacopoeial Convention, Inc., Rockville, MD, États-Unis (2019).
(2)...

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed? Log in!